Overview

Glyconanoparticles are nanoscale particles with unique glycan molecular functionalities that have important applications in various fields such as cancer therapy, vaccine development, and fertilizer delivery. They greatly improve the utilization efficiency of various active substances through precise targeted delivery mechanisms. For example, in cancer therapy, they precisely deliver anti-cancer drugs to tumor cells and reduce the damage to healthy cells. As a leader in the field of nanotechnology, CD BioGlyco offers glyconanoparticle delivery evaluation services based on various in vivo models. With our deep experience in glyconanoparticle research, we extract valuable insights to precisely meet the diversified R&D needs in biomedical, cosmetic, agricultural, and other fields.

Precise Delivery, Efficient Evaluation

We carefully design and synthesize glyconanoparticles with unique functionalities and promising broad applications, and conduct detailed in vivo studies to gain insights into their behavior in biological systems. Specific experimental procedures include the following:

Glyconanoparticle Development

We carefully design the glyconanoparticle based on actual delivery requirements and synthesize it under optimized conditions to ensure its functionalization. Afterward, we remove unreacted monomers and other reagents by dialysis and other steps. The resulting glyconanoparticle is then subjected to rigorous characterization to ensure that it has the desired properties for subsequent application in active substance delivery, diagnostics, or targeted therapy. The types of glyconanoparticles developed are diverse and include the following:

Glyconanoparticle Characterization

We perform detailed characterization of the Physicochemical Properties and Interactions of glyconanoparticles, including particle size, internal structure, pore size, particle shape, surface area, zeta potential, binding affinity, and more. Our many years of expertise and extensive instrumentation ensure that we offer the widest range of solutions for glyconanoparticle characterization.

• Dynamic light scattering (DLS) evaluates particle size distribution and determines surface charge to gain insight into stability and aggregation behavior.
• Transmission electron microscopy (TEM) or scanning electron microscopy (SEM) is used for high-resolution imaging to confirm the size and morphology of glyconanoparticles.
• Fourier transform infrared spectroscopy (FTIR) and nuclear magnetic resonance (NMR) spectroscopy are used to analyze the chemical structure of glyconanoparticles and confirm successful functionalization.
• Surface plasmon resonance (SPR) and other technologies are used to analyze the binding affinity of glyconanoparticles.
• Interactions of glyconanoparticles with specific proteins, lipids, carbohydrates, etc., are also studied to gain insight into their biological efficacy.

Glyconanoparticle Preclinical Studies

Utilizing the well-established GlycoNano™ Platform, we offer comprehensive animal model-based preclinical research services on glyconanoparticles to inform its applications such as drug delivery.

We offer two main types of in vivo models to study the delivery efficiency of glyconanoparticles, including the following:

We also customize other in vivo models to ensure that we accurately meet our clients' actual research needs. Based on these modeling options, we offer glyconanoparticle delivery evaluation services including, but not limited to, the following.

• Biodistribution studies: We track the distribution of glyconanoparticles in different organs and tissues by techniques such as fluorescence imaging, radiolabeling, or mass spectrometry after administration of glyconanoparticles using appropriate regimens.
• Pharmacokinetic Study: The absorption, metabolism, and excretion of glyconanoparticles after administration are studied in detail, and the half-life is analyzed.
• Immune Response Assessment: The immune response induced by glyconanoparticle is evaluated by measuring cytokines, immune cell activation markers, etc.
• Pharmacodynamic Studies: We evaluate the dose response, mechanism of action, etc., of glyconanoparticles by measuring various key parameters.
• Safety Pharmacology evaluation: We evaluate the potentially toxic effects of glyconanoparticles on organs and tissues by histologic examination, serum biochemical testing, or monitoring of adverse reactions.
  • Glyconanoparticle Acute Toxicity Study Service
  • Glyconanoparticle Chronic Toxicity Study Service
  • Glyconanoparticle Genotoxicity Study Service
  • Glyconanoparticle Cardiotoxicity Study Service
  • Glyconanoparticle Neurotoxicity Study Service
  • Glyconanoparticle Reproductive Toxicity Study Service

Workflow

We offer a customized in vivo model-based glyconanoparticle delivery evaluation service. The process begins with the selection of a suitable material to ensure that the properties are precisely tailored to the actual needs. This is followed by a series of rigorous characterization techniques to verify the accuracy of the glyconanoparticle. The final stage involves comprehensive in vivo testing to assess biocompatibility, pharmacokinetics, and overall efficacy. Throughout this process, our dedicated team of professionals continuously addresses challenges and optimizes design solutions to provide the best possible service experience.

Applications

• Evaluation of glyconanoparticle delivery using in vivo models provides useful information for developing glyconanoparticle-based targeted anticancer strategies.
• Evaluation of glyconanoparticle delivery using in vivo modeling can help advance glyconanoparticle research about targeted delivery of drugs for neurological disorders.
• Evaluation of glyconanoparticle delivery using in vivo models provides useful information for developing glyconanoparticle-based vaccines.

Advantages

• Through our services, we provide a comprehensive understanding of glyconanoparticle behavior in vivo, elucidating its delivery mechanisms and interactions with biological systems.
• We provide efficient study design and facilitate the smooth progress of research projects from concept to results.
• We provide expert guidance and support to ensure that clients conduct follow-up experiments in response to glyconanoparticle delivery assessment results.

Publication Data

Frequently Asked Questions

• What glyconanoparticle studies are performed in vivo?
  • Safety pharmacology assessments
  • Biodistribution studies
  • Pharmacology studies
  • Immune response studies
  • Pharmacokinetic studies
• Is the in vivo model-based glyconanoparticle delivery assessment program customizable and how long does it take?
  This service can certainly be customized. Our researchers will customize the protocol to meet specific needs and communicate with you. Depending on the complexity of the study, model selection, and analytical methods, glyconanoparticle delivery assessment timelines vary. We submit our experimental protocols with a time schedule and complete each experiment efficiently and accurately according to strict quality standards.

CD BioGlyco utilizes a rich set of in vivo models for a detailed evaluation of the efficacy and safety of glyconanoparticle delivery of various drugs and activators. Please feel free to contact us to learn more about our programs if you have detailed needs in this area.